Results 171 to 180 of about 44,701 (229)

Rapid peripheral reprogramming of myelinated afferents drives human hyperalgesia

open access: yes
Bouchatta O   +16 more
europepmc   +1 more source

Opioid hyperalgesia

Current Opinion in Supportive & Palliative Care, 2010
Opioids are invaluable in the treatment of moderate-to-severe pain. Unfortunately, their prolonged use may be associated with the onset of opioid-induced hyperalgesia (OIH). This review focuses on recent clinical studies that support or refute the existence of OIH in patients.Whether or not OIH is a clinical reality is an ongoing debate.
Kirsty, Bannister, Anthony H, Dickenson
openaire   +2 more sources

Opioid-Induced Hyperalgesia

Journal of PeriAnesthesia Nursing, 2012
HYPERALGESIAMEANS INCREASED sensitivity to pain. Opioid-induced hyperalgesia (OIH) is a paradoxical situation in which increasing doses of opioid result in increasing sensitivity to pain. OIH has been identified as a clinical reality, but the incidence of clinically significant OIH is unknown.
Chris, Pasero, Margo, McCaffery
openaire   +4 more sources

Opioid Tolerance and Hyperalgesia

Medical Clinics of North America, 2007
Opioids have been successfully used for the management of acute and cancer-related pain. Concerns regarding side effects, tolerance, dependence, addiction, and hyperalgesia have limited the use of opioids for the management of chronic nonmalignant pain.
Grace, Chang, Lucy, Chen, Jianren, Mao
openaire   +2 more sources

Deep Tissue Hyperalgesia

Journal of Musculoskeletal Pain, 2002
SUMMARYObjectives: The aim of this paper is to give a brief introduction to the mechanisms and manifestations related to muscle hyperalgesia. It has become increasingly evident that muscle hyperalgesia plays an important role in chronic musculoskeletal pain.
Arendt-Nielsen, Lars   +1 more
openaire   +3 more sources

Spinal Mediators of Hyperalgesia

Drugs, 1994
Neuronal plasticity associated with altered sensations arising from tissue damage involves both established (e.g. substance P and excitatory amino acids) and novel (e.g. nitric oxide and metabolites of arachidonic acid) mediators released from terminals of primary afferent neurons or synthesised in the spinal cord.
S T, Meller, G F, Gebhart
openaire   +2 more sources

Home - About - Disclaimer - Privacy